Skip to main content

Drug Discovery: Concepts and Approaches

  • Chapter
  • First Online:
Essentials of Bioinformatics, Volume I

Abstract

Current modern drug discovery and development was driven by complex innovative approaches, where the novel chemical moieties are identified and their pharmacological efficacy was well established. Eventhough, advancement in drug discovery approaches, drug development is still an expensive, lengthy, and difficult process associated with a high attrition rate. For developing single drug it may take about 10–15 years and cost $1–1.8 billion. This process underpins the discovery and development efforts of all pharmaceutical companies, encompassing the early stages of research, starting from target identification, proceeding to validation and then the identification of a lead compound or drug candidate. Following this identification, the drug discovery pipeline consists of hit identification, lead optimization, and determination of toxicity, with animal model testing and finally clinical studies. Once a compound fulfills all the requirements, it is subjected to the drug development process after which preclinical studies and clinical studies are performed. If the lead compound is successful, it is ultimately marketed.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 189.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 249.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Arun B (2009) Challenges in drug discovery: can we improve drug development. J Bioanal Biomed 1:050–053

    Google Scholar 

  • Baumeister AA, Pow JL, Henderson K, Lopez-Munoz F (2013) On the exploitation of serendipity in drug discovery. Clin Exp Pharmacol 3:3

    Google Scholar 

  • Chassell IP, Hatcher JP, Bountra C, Michel AD, Hughes JP, Green P (2005) Disruption of the P2X7 purinoceptor gene abolishes chronic inflammatory and neuropathic pain. Pain 114:386–396

    Google Scholar 

  • Cohen JS, Hogan ME (1994) The new genetic medicines. Sci Am 271:50–55

    Google Scholar 

  • Fox S, Farr-Jones S, Sopchak L, Boggs A, Nicely AW, Khoury R et al (2006) High-throughput screening; update on practices and success. J Biomol Screen 11:864–869

    PubMed  Google Scholar 

  • Giridhar R (2012) Drug discovery: past and present. J Adv Pharm Technol Res 3(1):2

    PubMed  PubMed Central  Google Scholar 

  • Henning SW, Beste G (2002) Loss of function strategies in drug target validation. Curr Drug Discov 2:17–21

    Google Scholar 

  • Hughes JP, Rees S, Kalindjian SB, Philpott KL (2011) Principles of early drug discovery. Br J Pharmacol 162:1239–1249

    CAS  PubMed  PubMed Central  Google Scholar 

  • Landau R, Achilladelis B, Scriabine (1999) Pharmaceutical Innovation, Philadelphia: Chemical Hertage Press

    Google Scholar 

  • Liu R, Li X, Lam KS (2017) Combinatorial chemistry in drug discovery. Curr Opin Chem Biol 38:117–126

    CAS  PubMed  PubMed Central  Google Scholar 

  • Medina-Franco JL (2012) Drug discovery with novel chemical libraries. Drug Des 1:e105

    Google Scholar 

  • Nicolson TJ (2010) The post transcriptional regulator EIF 2S3 and gender differences in the dog. Implications for drug development, drug efficacy and safety profiles. J Drug Metab Toxicol 1:101

    Google Scholar 

  • Parasuraman S (2011) Toxicological screening. J Pharmacother 2(2):74–79

    CAS  Google Scholar 

  • Sanchez HEP (2012) Exploitation of massively parallel architectures of drug discovery. Drug Des 2:e108

    Google Scholar 

  • Sang N (2011) Biochemistry, drug development and open access. Biochem Pharmacol 1:e101

    Google Scholar 

  • Tamimi NAM, Ellis P (2009) Drug development: from concept to marketing. Nephron Clin Pract 113:c125–c131

    CAS  PubMed  Google Scholar 

  • Torzewski J (2011) Road map to drug discovery and development – inhibiting C-reactive protein for the treatment of cardiovascular disease. J Bioequiv Availab S1:001

    Google Scholar 

  • Xiao X, Min JL, Lin WZ, Liu Z (2015) iDrug-Target: predicting the interactions between drug compounds and target proteins in cellular networking via the benchmark dataset optimization approach. J Biomol Struct Dyn 33:2221–2233

    CAS  PubMed  Google Scholar 

  • Yang Z, Marotta F (2012) Pharmacometabolomics in drug discovery and development; applications and challenges. Metabolomics 2:e122

    Google Scholar 

  • Yang Y, Adelstein SJ, Kassis AL (2009) Target discovery from data mining approaches. Drug Discov Today 14:147–154

    PubMed  Google Scholar 

  • Zhong WZ, Zhou SF (2014) Molecular science for drug development and biomedicine. Int J Mol Sci 15:20072–20078

    CAS  PubMed  PubMed Central  Google Scholar 

  • Zhou S-F, Zhong W-Z (2017) Drug design and discovery – principles and applications. Molecules 22:279

    PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Reddy, V.D.K., Banaganapalli, B., Rajitha, G. (2019). Drug Discovery: Concepts and Approaches. In: Shaik, N., Hakeem, K., Banaganapalli, B., Elango, R. (eds) Essentials of Bioinformatics, Volume I. Springer, Cham. https://doi.org/10.1007/978-3-030-02634-9_14

Download citation

Publish with us

Policies and ethics